Wound Biologics Market by Product (Biologic Skin Substitutes, Topical Agents), Wound Type (Burns, Surgical and Traumatic Wounds, Ulcers), End-User - Global Forecast 2024-2030

Wound Biologics Market by Product (Biologic Skin Substitutes, Topical Agents), Wound Type (Burns, Surgical and Traumatic Wounds, Ulcers), End-User - Global Forecast 2024-2030


The Wound Biologics Market size was estimated at USD 4.98 billion in 2023 and expected to reach USD 5.43 billion in 2024, at a CAGR 9.99% to reach USD 9.70 billion by 2030.

Global Wound Biologics Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Wound Biologics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Wound Biologics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Wound Biologics Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Anika Therapeutics, Inc, Avita Medical, Inc., B. Braun SE, Bioventus Inc., Blaine Labs Inc., ConvaTec Group PLC, Cytori Therapeutics Inc., Fibroheal Woundcare Pvt Ltd, Integra Lifesciences Holdings Corporation, Kerecis hf, Marine Polymer Technologies, Inc., MediWound Ltd., Medline Industries, LP, Merakris Therapeutics, Inc., MIMEDX GROUP, INC., Mölnlycke Health Care AB, Nuo Therapeutics, Inc., Organogenesis Inc., Polymedics Innovations GmbH, Royal Biologics, Inc., Skye Biologics Holdings, LLC, Smith & Nephew PLC, Stability Biologics, Stryker Corporation, Surgilogix, LLC, Tides Medical, Vericel Corporation, Viatris Inc., and Vivex Biologics.

Market Segmentation & Coverage

This research report categorizes the Wound Biologics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
Biologic Skin Substitutes
Acellular Animal-derived Products
Biosynthetic Products
Human Donor Tissue-derived Products
Topical Agents
Wound Type
Burns
Surgical and Traumatic Wounds
Ulcers
Diabetic Foot Ulcers
Pressure Ulcers
Venous Ulcers
End-User
Ambulatory Surgery Centers
Burn Centers
Hospitals
Wound Clinics
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Wound Biologics Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Wound Biologics Market?
3. What are the technology trends and regulatory frameworks in the Wound Biologics Market?
4. What is the market share of the leading vendors in the Wound Biologics Market?
5. Which modes and strategic moves are suitable for entering the Wound Biologics Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Wound Biologics Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Government Initiatives Regarding Wound Care Treatment
5.1.1.2. Rising Incidences of Burn Injuries and Road Accidents
5.1.1.3. Increasing Geriatric Population Globally
5.1.2. Restraints
5.1.2.1. High Cost of Wound Treatment
5.1.3. Opportunities
5.1.3.1. Introduction of Innovative Wound Care Biologics
5.1.3.2. Potential Need for Bioengineered Skin Substitutes in Surgeries
5.1.4. Challenges
5.1.4.1. Lack of Trained Physicians and Complications Associated with the Contamination
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Wound Biologics Market, by Product
6.1. Introduction
6.2. Biologic Skin Substitutes
6.3.1. Acellular Animal-derived Products
6.3.2. Biosynthetic Products
6.3.3. Human Donor Tissue-derived Products
6.3. Topical Agents
7. Wound Biologics Market, by Wound Type
7.1. Introduction
7.2. Burns
7.3. Surgical and Traumatic Wounds
7.4. Ulcers
7.5.1. Diabetic Foot Ulcers
7.5.2. Pressure Ulcers
7.5.3. Venous Ulcers
8. Wound Biologics Market, by End-User
8.1. Introduction
8.2. Ambulatory Surgery Centers
8.3. Burn Centers
8.4. Hospitals
8.5. Wound Clinics
9. Americas Wound Biologics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Wound Biologics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Wound Biologics Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. 3M Company
13.1.2. Anika Therapeutics, Inc
13.1.3. Avita Medical, Inc.
13.1.4. B. Braun SE
13.1.5. Bioventus Inc.
13.1.6. Blaine Labs Inc.
13.1.7. ConvaTec Group PLC
13.1.8. Cytori Therapeutics Inc.
13.1.9. Fibroheal Woundcare Pvt Ltd
13.1.10. Integra Lifesciences Holdings Corporation
13.1.11. Kerecis hf
13.1.12. Marine Polymer Technologies, Inc.
13.1.13. MediWound Ltd.
13.1.14. Medline Industries, LP
13.1.15. Merakris Therapeutics, Inc.
13.1.16. MIMEDX GROUP, INC.
13.1.17. Mölnlycke Health Care AB
13.1.18. Nuo Therapeutics, Inc.
13.1.19. Organogenesis Inc.
13.1.20. Polymedics Innovations GmbH
13.1.21. Royal Biologics, Inc.
13.1.22. Skye Biologics Holdings, LLC
13.1.23. Smith & Nephew PLC
13.1.24. Stability Biologics
13.1.25. Stryker Corporation
13.1.26. Surgilogix, LLC
13.1.27. Tides Medical
13.1.28. Vericel Corporation
13.1.29. Viatris Inc.
13.1.30. Vivex Biologics
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
FIGURE 1. WOUND BIOLOGICS MARKET RESEARCH PROCESS
FIGURE 2. WOUND BIOLOGICS MARKET SIZE, 2023 VS 2030
FIGURE 3. WOUND BIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. WOUND BIOLOGICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. WOUND BIOLOGICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. WOUND BIOLOGICS MARKET DYNAMICS
FIGURE 7. WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2023 VS 2030 (%)
FIGURE 10. WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. WOUND BIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. WOUND BIOLOGICS MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings